AG 556

Discontinued Product

0616 has been discontinued.

View all EGFR products.
说明: EGFR-kinase inhibitor
别名: Tyrphostin AG 556
化学名: (E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-2-propenamide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for AG 556

Epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 1.1 μM). Selective over ErbB2 (IC50 > 500 μM).

技术数据 for AG 556

分子量 336.39
公式 C20H20N2O3
储存 Desiccate at +4°C
纯度 ≥99% (HPLC)
CAS Number 133550-41-1
PubChem ID 5328775
InChI Key GWCNJMUSWLTSCW-SFQUDFHCSA-N
Smiles OC1=C(O)C=C(\C=C(/C#N)C(=O)NCCCCC2=CC=CC=C2)C=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for AG 556

参考文献是支持产品生物活性的出版物。

Gamett et al (1997) Secondary dimerization between members of the epidermal growth factor receptor family. J.Biol.Chem. 272 12052 PMID: 9115272

Gazit et al (1991) Tyrphostins. 2. Heterocyclic and α-substituted benzylidenemalononitrile tyrophostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J.Med.Chem. 34 1896 PMID: 1676428

按产品操作查看相关产品

查看全部 EGFR Inhibitors

关键词: AG 556, AG 556 supplier, EGFR, kinase, inhibitors, inhibits, Epidermal, Growth, Factors, Receptors, ErbB, Her, Receptor, Tyrosine, Kinases, RTKs, AG556, Tyrphostin, AG, 556, 0616, Tocris Bioscience

篇 AG 556 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 AG 556 的引用文献。

AG 556 的评论

目前没有该产品的评论。 Be the first to review AG 556 and earn rewards!

Have you used AG 556?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.